Ultrasound-guided foam sclerotherapy for severe chronic venous insufficiency

de-Abreu, Guilherme Camargo Gonçalves; Júnior, Otacílio de Camargo; de-Abreu, Márcia Fayad Marcondes; Aquino, José Luiz Braga de

doi:10.1590/0100-69912017005014

Cited by 14 publications

(6 citation statements)

References 77 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…to ablate veins, venules, and in general, any type of varicose manifestation in patients with CVD [ 315 ]. This therapy is indicated especially, but not only, in patients with baseline comorbidities, where more aggressive techniques could be contraindicated [ 316 ]. Moreover, sclerotherapy can be an alternative to other procedures in patients with advanced CVI and saphenous vein incompetence who are not candidates for surgery or endovenous techniques [ 317 ].…”

Section: Therapeutical Approaches In Cvdmentioning

confidence: 99%

Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management

Ortega

Fraile-Martínez

García-Montero

et al. 2021

JCM

120

View full text Add to dashboard Cite

Chronic venous disease (CVD) is a multifactorial condition affecting an important percentage of the global population. It ranges from mild clinical signs, such as telangiectasias or reticular veins, to severe manifestations, such as venous ulcerations. However, varicose veins (VVs) are the most common manifestation of CVD. The explicit mechanisms of the disease are not well-understood. It seems that genetics and a plethora of environmental agents play an important role in the development and progression of CVD. The exposure to these factors leads to altered hemodynamics of the venous system, described as ambulatory venous hypertension, therefore promoting microcirculatory changes, inflammatory responses, hypoxia, venous wall remodeling, and epigenetic variations, even with important systemic implications. Thus, a proper clinical management of patients with CVD is essential to prevent potential harms of the disease, which also entails a significant loss of the quality of life in these individuals. Hence, the aim of the present review is to collect the current knowledge of CVD, including its epidemiology, etiology, and risk factors, but emphasizing the pathophysiology and medical care of these patients, including clinical manifestations, diagnosis, and treatments. Furthermore, future directions will also be covered in this work in order to provide potential fields to explore in the context of CVD.

show abstract

Section: Therapeutical Approaches In Cvdmentioning

confidence: 99%

Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management

Ortega

Fraile-Martínez

García-Montero

et al. 2021

JCM

120

View full text Add to dashboard Cite

show abstract

“…34 It is recommended that patients be classified by CEAP grade to guide therapeutic decisions, but this classification is not very sensitive to slight changes in disease severity. 35 Notwithstanding, when we analyzed CEAP clinical severity at the two assessment times, we observed changes in the categories of some patients, primarily in the direction of improvement (reduction). However, in more severe CVD, small to moderate changes in QoL may remain undetected, leading to variability in the results, which increases significantly as disease severity increases and is responsible for discrepancies observed in the relationship between QoL and CEAP grade.…”

Section: Post-treatment Changesmentioning

confidence: 86%

Verificação da sensibilidade longitudinal do questionário de qualidade de vida AVVQ-Brasil ao tratamento não cirúrgico da doença venosa crônica

et al. 2019

View full text Add to dashboard Cite

RESUMO Contexto A sensibilidade determina a eficiência e a qualidade de construção de uma medida de avaliação, mas estudos sobre o tema são escassos na literatura. Objetivos Verificar a sensibilidade longitudinal do AVVQ-Brasil às mudanças clínicas após tratamento da doença venosa crônica (DVC). Métodos Estudo de intervenção longitudinal, 112 doentes venosos crônicos em tratamento eletivo, avaliados por CEAP, EVA dor, AVVQ-Brasil e VEINES-QOL/Sym, pré (basal) e pós-tratamento (4 semanas). As diferenças nas pontuações das escalas entre momentos foram avaliadas pelos testes t Student pareado e z de Wilcoxon, que avaliou também indivíduos por CEAP e momentos de avaliação. Tamanho do efeito, intervalo de confiança e η2 parcial verificaram a sensibilidade às mudanças nas pontuações das escalas ao longo do tempo. A correlação entre mudanças nas pontuações de mesmas escalas e entre diferentes escalas foi mensurada pelos coeficientes de Pearson, de Spearman e tau_b de Kendall. Resultados A idade média dos pacientes era de 59,51 anos. A maioria era do sexo feminino (82,1%), com postura em ortostatismo prolongado (49,1%), tinha ensino médio (22,3%) ou superior completo (25%), e apresentava gravidade clínica CEAP C2 (28,6%) ou C6 (32,1%). Foram observados os seguintes resultados: diminuição das médias das escalas entre momentos, exceto no domínio Extensão da Varicosidade do AVVQ-Brasil e no VEINES-QOL/Sym; sensibilidade pequena para AVVQ-Brasil e seus domínios e para EVA dor, e de pequena a grande para as demais escalas; melhora ou manutenção do CEAP pós-tratamento; e correlações moderadas a excelentes entre mudanças nas escalas ao longo do tempo. Conclusões O AVVQ-Brasil é longitudinalmente sensível às mudanças clínicas pós-tratamento da DVC, sendo medida importante de avaliação da QV e da gravidade da doença no Brasil.

show abstract

“…However, until now, it is not subjected to scientific scrutiny as other methods of endoablation -an art waiting for its science. [41] Despite the other endoablative methods, such as thermal endoablation (i.e., laser, radiofrequency and steam), chemical endoablation by FS is an attractive technique, as the requirement for tumescence, anesthesia and hospital admission are avoided. It also utilizes minimal paraphernalia used for obtaining a sterile operative field.…”

Section: Discussionmentioning

confidence: 99%

Complications of sclerotherapy

Patel¹

2021

Turk J Vasc Surg

View full text Add to dashboard Cite

Sclerotherapy is a popular, simple, safe, and effective alternative to ablation of refluxing veins in patients with chronic venous insufficiency due to chronic venous disease. Over the last two decades, we have used this method and its safer variant of ultrasound-guided foam sclerotherapy, solely or adjunctly, to ablate all types of superficial refluxing veins. In the course of therapy, we observed some complications, managed them, and discuss them in this review, along with some which have been reported in the literature. Our effort is to increase the use of this safe and straightforward method to ablate superficial refluxing.

show abstract

Ultrasound-guided foam sclerotherapy for severe chronic venous insufficiency

Cited by 14 publications

References 77 publications

Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management

Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management

Verificação da sensibilidade longitudinal do questionário de qualidade de vida AVVQ-Brasil ao tratamento não cirúrgico da doença venosa crônica

Complications of sclerotherapy

Contact Info

Product

Resources

About